课题基金 / 基金详情

Herpesviral Gene Expression in Kaposis Sarcoma

Herpesviral Gene Expression in Kaposis Sarcoma
卡波济肉瘤中的疱疹病毒基因表达
批准号:
6779787
负责人:
DON GANEM
金额:
$27.55万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-30 至 2006-08-31

项目摘要

项目成果

DON GANEM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Infection by Kaposi's sarcoma-associated herpesvirus (KSHV; also called human herpesvirus 8) is a key factor in the development of Kaposi's sarcoma (KS), a proliferative lesion of endothelial cells that until recently was the commonest neoplasm of AIDS patients. In KS tumors, the viral genome resides within the majority of spindle cells in a latent state; smaller numbers of tumor cells display lytic infection. This grant began with the examination of viral gene expression in KS tumors, identifying several latent and lytic genes expressed in that context. The present renewal application seeks to further characterize the expression and function of these genes. Specifically, we will (i) develop an endothelial cell culture model of KSHV latency and use it to develop a genetic system for the creation and analysis of mutant KSHV genomes; (ii) characterize the phenotypic consequences of expression of a major KSHV latency locus encoding orfs 71,72 and 73; (iii) further explore the mechanisms and consequences of constitutive signaling by the KSHV K1 protein; (iv) characterize the biochemical activities and interactions of the KSHV kaposin gene products; and (v) identify the constituents of an abundant viral ribonucleoprotein complex and determine their function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiology of lytic reactivation and spread of KSHV
Pathophysiology of lytic reactivation and spread of KSHV
Pathophysiology of lytic reactivation and spread of KSHV
Pathophysiology of lytic reactivation and spread of KSHV
海外基金